Insmed Joins Biotech Trash Heap
When a drug trial goes bad, the hit to a drug maker's stock is instant and spectacular. Wednesday it will be Insmed in the spotlight. Shares were down nearly 25% in premarket trading.
When a drug trial goes bad, the hit to a drug maker's stock is instant and spectacular. Wednesday it will be Insmed in the spotlight. Shares were down nearly 25% in premarket trading.
Frank Golhen, via Wikimedia CommonsWith volatility edging ever higher, investors have to look for at least a synthetic hedge to help them should there be a sizable correction. One of the best is solid…
ThinkstockThe Mortgage Bankers Association (MBA) released its weekly report on mortgage applications Wednesday morning, noting a decrease of 3.5% in the group’s seasonally adjusted composite index. That followed a rise of 0.2% for the…
Jon OggIn case you haven’t been paying attention lately, value stocks are starting to get some interest again. In fact, the dog of all technology value stock dogs named International Business Machines Corp. (NYSE:…
After retreating from many leading biotech and emerging pharmaceutical stocks in the previous two periods, short sellers returned in early March, especially in Celgene, Medivation and Pharmacyclics.
ThinkstockShort interest in the 3D printing companies was mixed in the most recent two-week reporting period. Partly that is due to the poor performance of the stocks since the beginning of the year. The…
Despite the rise of online properties such as Twitter, Pinterest and BuzzFeed, the sites that dominate the list of those most visited by Americans are the portals and search site Google.
Short sellers continue to hold huge positions in troubled companies, including J.C. Penney, while adding to their positions in some of the largest tech firms, such as Intel.
ThinkstockFacebook Inc. (NASDAQ: FB) already made major news and noise when it acquired WhatsApp for a zany sum of $19 billion. Now Mark Zuckerberg is making another large deal. Facebook is acquiring virtual reality…
Twitter Inc. (NYSE: TWTR) proved that the cautious bears were way wrong right after the initial public offering. The microblogging giant sold shares at $26 in the IPO in late 2013, but the lowest…
ThinkstockInternational Game Technology (NYSE: IGT) had a dubious title for a press release. It was named “IGT Re-Aligns to Position for Long-Term Earnings Growth.” The company should ask its employees, or at least 7%…
ThinkstockKohl’s Corp. (NYSE: KSS) may have a mixed bag on the news reaction that the company’s chief merchandising officer is leaving the company. This sort of news can be a disaster for a retailer,…
thinkstockMarch 25, 2014: Markets opened higher on Tuesday but dipped sharply in the late morning on weakness in consumer discretionary, financial, and biotech stocks. The Dow and the S&P 500 held on to decent…
Courtesy of Boeing Co.The U.S. Federal Aviation Administration (FAA) on Tuesday issued an airworthiness directive to The Boeing Co. (NYSE: BA) requiring the company install new software that could prevent a crash on the…
When BlackBerry opened up its popular messaging application, BBM, to iOS and Android last year, it more than doubled the user base. The questions is, is there any money in it?